Telix Gains FDA Approval for Pixclara in Glioma Imaging
MELBOURNE, Australia and INDIANAPOLIS, Ind. — September 14, 2026 Telix Pharmaceuticals announced that the U.S. Food and Drug Administration...
TLX101-Px
Advertisement
Telix and United Imaging Partner to Advance AI-Driven Theranostics
MELBOURNE, Australia; INDIANAPOLIS, Indiana; and HOUSTON, Texas, June 2, 2026 Telix Pharmaceuticals and United Imaging Healthcare North America have...
Telix Resubmits NDA for TLX101-Px Brain Cancer Imaging Agent
MELBOURNE, Australia and INDIANAPOLIS, United States, March 16, 2026 Telix Pharmaceuticals has announced the resubmission of a New Drug...
Advertisement
